Late Toxicity of Radiation for Breast Cancer: Overblown or Underappreciated?
Late Toxicity of Radiation for Breast Cancer: Overblown or Underappreciated? is organized by American Society for Radiation Oncology (ASTRO).
Start Date:Dec 13, 2017
Expire Date:Dec 12, 2020
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This session will focus on late toxicity of radiation for breast cancer, with the theme of whether these risks are overblown or under-appreciated. Along with the introduction and a question and answer session, there are four videos, each approximately 15 minutes:
• Impact of Radiation on Reconstruction after Mastectomy
• Risk of Lymphedema after Radiation for Breast Cancer
• Risk of Cardiac Morbidity and Mortality after Radiation for Breast Cancer
• Risk of Second Malignancy after Radiation for Breast Cancer
• The focus will be on tailored risk assessment for each of these potential toxicities, considerations for including risk of toxicity in management decisions, and toxicity management strategies.
After this session, attendees should be able to:
• Define the impact of radiation on reconstruction after mastectomy.
• Identify lymphedema risks and apply strategies for risk reduction.
• Identify cardiac risks and develop tools for including risk assessment in management decisions.
- CME : 1.5
This program is designed to meet the interest of radiation oncologists, radiation therapists, and radiation dosimetrists.
Number of Health Care Professionals Registered: 0 Number
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine